Jack Bendheim

Insider Reports History

Reporting-owner location: Teaneck, NJ
Latest reporting-owner signature: /s/ Judith Weinstein, as Attorney-in-Fact for Jack Bendheim
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Jack Bendheim

Form 4 holding Executive Chairman, Director, 10%+ Owner

PHIBRO ANIMAL HEALTH CORP

Security class: Class A Common Stock
Shares / value: 56,152
Estimated value: $1,763,172
Report date: 06 Aug 2026
Price: $31.40
Ownership: See

Form 4 holding Executive Chairman, Director, 10%+ Owner

PHIBRO ANIMAL HEALTH CORP

Security class: Class A Common Stock
Shares / value: 26,640
Estimated value: $836,496
Report date: 06 Aug 2026
Price: $31.40
Ownership: Direct

Form 4 holding Executive Chairman, Director, 10%+ Owner

PHIBRO ANIMAL HEALTH CORP

Security class: Class B Common Stock
Shares / value: 19,496,034
Estimated value
Report date: 16 Apr 2026
Price
Ownership: See
Underlying class: Class A Common Stock
Underlying amount

Insider Reports Filed by Jack Bendheim

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 06 Aug 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 10 Aug 2026, 16:16
Role: Executive Chairman, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 04 Aug 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Aug 2026, 20:12
Role: Executive Chairman, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 05 May 2026
Transactions: 7
Transaction value: -$1,016,228
Accepted by SEC: 07 May 2026, 19:34
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 28 Apr 2026
Transactions: 7
Transaction value: -$1,137,593
Accepted by SEC: 30 Apr 2026, 19:20
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 21 Apr 2026
Transactions: 5
Transaction value: -$1,157,091
Accepted by SEC: 23 Apr 2026, 19:30
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 14 Apr 2026
Transactions: 9
Transaction value: -$1,201,595
Accepted by SEC: 16 Apr 2026, 20:25
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 30 Mar 2026
Transactions: 4
Transaction value: -$756,834
Accepted by SEC: 31 Mar 2026, 18:44
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 24 Mar 2026
Transactions: 7
Transaction value: -$1,166,105
Accepted by SEC: 26 Mar 2026, 21:19
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 17 Mar 2026
Transactions: 7
Transaction value: -$1,198,818
Accepted by SEC: 19 Mar 2026, 19:58
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 12 Mar 2026
Transactions: 3
Transaction value: -$258,245
Accepted by SEC: 16 Mar 2026, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 24 Feb 2026
Transactions: 5
Transaction value: -$1,103,938
Accepted by SEC: 26 Feb 2026, 19:09
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 19 Feb 2026
Transactions: 3
Transaction value: -$715,775
Accepted by SEC: 23 Feb 2026, 16:30
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 13 Feb 2026
Transactions: 3
Transaction value: -$727,646
Accepted by SEC: 18 Feb 2026, 19:40
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 10 Feb 2026
Transactions: 4
Transaction value: -$3,737,711
Accepted by SEC: 11 Feb 2026, 18:27
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 05 Feb 2026
Transactions: 8
Transaction value: -$5,362,103
Accepted by SEC: 09 Feb 2026, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 03 Feb 2026
Transactions: 5
Transaction value: -$545,473
Accepted by SEC: 05 Feb 2026, 19:22
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 29 Jan 2026
Transactions: 2
Transaction value: -$540,037
Accepted by SEC: 02 Feb 2026, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 23 Jan 2026
Transactions: 3
Transaction value: -$50,084
Accepted by SEC: 27 Jan 2026, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 21 Jan 2026
Transactions: 3
Transaction value: -$1,164,547
Accepted by SEC: 22 Jan 2026, 19:41
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 13 Jan 2026
Transactions: 6
Transaction value: -$569,753
Accepted by SEC: 15 Jan 2026, 18:24
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 09 Jan 2026
Transactions: 1
Transaction value: -$8,554
Accepted by SEC: 13 Jan 2026, 18:53
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 07 Jan 2026
Transactions: 1
Transaction value: -$13,149
Accepted by SEC: 08 Jan 2026, 18:07
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 11 Dec 2025
Transactions: 2
Transaction value: -$235,405
Accepted by SEC: 15 Dec 2025, 16:51
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 08 Dec 2025
Transactions: 2
Transaction value: -$192,781
Accepted by SEC: 10 Dec 2025, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 03 Dec 2025
Transactions: 5
Transaction value: -$288,607
Accepted by SEC: 04 Dec 2025, 18:34
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 28 Nov 2025
Transactions: 2
Transaction value: -$296,376
Accepted by SEC: 02 Dec 2025, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 25 Nov 2025
Transactions: 2
Transaction value: -$541,674
Accepted by SEC: 26 Nov 2025, 17:46
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 20 Nov 2025
Transactions: 2
Transaction value: -$147,002
Accepted by SEC: 24 Nov 2025, 16:15
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 14 Nov 2025
Transactions: 5
Transaction value: -$466,631
Accepted by SEC: 18 Nov 2025, 19:50
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 11 Nov 2025
Transactions: 5
Transaction value: -$1,365,393
Accepted by SEC: 13 Nov 2025, 20:24
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 07 Nov 2025
Transactions: 5
Transaction value: -$1,885,618
Accepted by SEC: 10 Nov 2025, 19:50
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 04 Nov 2025
Transactions: 6
Transaction value: -$296,778
Accepted by SEC: 06 Nov 2025, 17:46
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 28 Oct 2025
Transactions: 3
Transaction value: -$437,487
Accepted by SEC: 30 Oct 2025, 18:09
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 22 Oct 2025
Transactions: 3
Transaction value: -$765,941
Accepted by SEC: 24 Oct 2025, 19:06
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 17 Oct 2025
Transactions: 4
Transaction value: -$677,198
Accepted by SEC: 21 Oct 2025, 17:30
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 30 Sep 2025
Transactions: 1
Transaction value: -$834,412
Accepted by SEC: 01 Oct 2025, 16:10
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 18 Sep 2025
Transactions: 3
Transaction value: -$282,732
Accepted by SEC: 22 Sep 2025, 18:32
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 09 Sep 2025
Transactions: 3
Transaction value: -$857,313
Accepted by SEC: 11 Sep 2025, 20:56
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

4 PAHC

PHIBRO ANIMAL HEALTH CORP

Report period: 15 Aug 2025
Transactions: 1
Transaction value: $0
Accepted by SEC: 19 Aug 2025, 16:16
Role: President and CEO, Director, 10%+ Owner
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .